On-line solid-phase extraction with ultra performance liquid chromatography and tandem mass spectrometry for the detection of nicotine, cotinine and trans-3'-hydroxycotinine in urine to strengthen human biomonitoring and smoking cessation studies

Journal of Pharmaceutical and Biomedical Analysis

Volumn 76, Issue , 2013, Pages 126-133

  De Cremer, Koen ^a   Van Overmeire, Ilse ^a   Van Loco, Joris ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

Biomonitoring; Cotinine; On line SPE; UPLC; Urine

Indexed keywords

3' HYDROXYCOTININE; COTININE; NICOTINE; TOBACCO SMOKE;

ADULT; ARTICLE; AUTOMATION; BIOLOGICAL MONITORING; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PASSIVE SMOKING; PATIENT MONITORING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMOKING CESSATION; SOLID PHASE EXTRACTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; URINE; URINE LEVEL;

CHROMATOGRAPHY, LIQUID; COTININE; ENVIRONMENTAL EXPOSURE; HUMANS; NICOTINE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SMOKING; SMOKING CESSATION; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TOBACCO SMOKE POLLUTION;

EID: 84872244926     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.12.018     Document Type: Article

References (41)

1. Angerer J., Ewers U., Wilhelm M. Human biomonitoring: state of the art. Int. J. Hyg. Environ. Health 2007, 210:201-228.
2. Kuklenyik Z., Ye X., Needham L.L., Calafat A.M. Automated solid-phase extraction approaches for large scale biomonitoring studies. J. Chromatogr. Sci. 2009, 47:12-18.
3. Churchwell M.I., Twaddle N.C., Meeker L.R., Doerge D.R. Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ESI-MS/MS to HPLC-ESI-MS/MS. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2005, 825:134-143.
4. Petsalo A., Turpeinen M., Pelkonen O., Tolonen A. Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2μm particle size column. J. Chromatogr. A 2008, 1215:107-115.
5. West O., Hajek P., McRobbie H. Systematic review of the relationship between the 3'-hydroxycotinine/cotinine ratio and cigarette dependence. Psychopharmacol. 2011, 218:313-322.
6. Benowitz N.L., Jacob P.J. Nicotine chemistry metabolism, kinetics and biomarkers. Handb. Exp. Pharmacol. 2009, 192:29-60.
7. Benowitz N.L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol. Rev. 1996, 18:188-204.
8. Schnoll R.A., Patterson F., Wileyto E.P., Tyndale R.F., Benowitz N., Lerman C. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol. Biochem. Behav. 2009, 92:6-11.
9. Sofuoglu M., Herman A.I., Nadim H., Jatlow P. Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine. Neuropschychopharmacol. 2012, 37:1509-1516.
10. St Helen G., Novalen M., Heitjan D.F., Dempsey D., Jacob P.J., Aziziyeh A., Wing V.C., George T.P., Tyndale R.F., Benowitz N.L. Reproducibility of the nicotine metabolic ratio in cigarette smokers. Cancer Epiemiol. Biomarkers Prev. 2012, 21:1105-1114.
11. Baumann F., Regenthal R., Burgos-Guerrero I.L., Hegerl U., Preiss R. Determination of nicotine and cotinine in human serum by means of LC-MS. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2010, 878:107-111.
12. Jacob P.J., Yu L., Duan M., Ramos L., Yturralde O., Benowitz N.L. Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2011, 879:267-276.
13. Heavner D.L., Richardson J.D., Morgan W.T., Ogden M.W. Validation and application of a method for the determination of nicotine and five major metabolites in smokers' urine by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 2005, 19:312-328.
14. Hoofnagle A.N., Laha T.J., Rainey P.M., Sadrzadeh S.M.H. Specific detection of anabasine, nicotine, and nicotine metabolites in urine by liquid chromatography-tandem mass spectrometry. Am. J. Clin. Pathol. 2006, 126:880-887.
15. Huerta-Fontela M., Galceran M.T., Martin-Alonso J., Ventura F. Occurrence of psychoactive stimulatory drugs in wastewaters in north-eastern Spain. Sci. Total Environ. 2008, 397:31-40.
16. Marclay F., Saugy M. Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatography-tandem mass spectrometry: potential use of smokeless tobacco products by ice hockey players. J. Chromatogr. A 2010, 1217:7528-7538.
17. Meger M., Meger-Kossien I., Schuler-Metz A., Janket D., Scherer G. Simultaneous determination of nicotine and eight nicotine metabolites in urine of smokers using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2002, 778:251-261.
18. Miller E.I., Norris H.R.K., Rollins D.E., Tiffany S.T., Wilkins D.G. A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2010, 878:725-737.
19. Moyer T.P., Charlson J.R., Enger R.J., Dale L.C., Ebbert J.O., Schroeder D.R., Hurt R.D. Simultaneous analysis of nicotine, nicotine metabolites and tobacco alkaloids in serum or urine by tandem mass spectrometry with clinically relevant metabolic profiles. Clin. Chem. 2002, 48:1460-1471.
20. Rangiah K., Hwang W.T., Mesaros C., Vachani A., Blair I.A. Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS. Bioanalysis 2011, 3:745-761.
21. Scheidweiler K.B., Shakleya D.M., Huestis M.A. Simultaneous quantification of nicotine, cotine, trans-3'-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography-tandem mass spectrometry. Clin. Chim. Acta 2012, 413:978-984.
22. Shakleya D.M., Huestis M.A. Simultaneous and sensitive measurement of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2009, 877:3537-3542.
23. Shakleya D.M., Huestis M.A. Optimization and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human oral fluid. Anal. Bioanal. Chem. 2009, 395:2349-2357.
24. Song L., Davis W., Abrams S.M., Hemiup J., Kazim A.L., Cummings K.M., Mahoney M.C. Sensitive and rapid method for the determination of urinary cotinine in non-smokers: an application for studies assessing exposures to second hand smoke (SHS). Anal. Chim. Acta 2005, 545:200-208.
25. Xu X., Iba M.M., Weisel C.P. Simultaneous and sensitive measurement of anabasine, nicotine, and nicotine metabolites in human urine by liquid chromatography-tandem mass spectrometry. Clin. Chem. 2004, 50:2323-2330.
26. Chao M.R., Wang C.J., Yang H.H., Chang L.W., Hu C.W. Rapid and sensitive quantification of urinary N7-methylguanine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry with on-line solid-phase extraction. Rapid Commun. Mass Spectrom. 2005, 19:2427-2432.
27. Hu C.W., Chang Y.Z., Wang H.W., Chao M.R. High-throughput simultaneous analysis of five urinary metabolites of areca nut and tobacco alkaloids by isotope-dilution liquid chromatography-tandem mass spectrometry with on-line solid phase extraction. Cancer Epidemiol. Biomarkers Prev. 2010, 19:2570-2581.
28. Kataoka H., Inoue R., Yagi K., Saito K. Determination of nicotine, cotinine, and related alkaloids in human urine and saliva by automated in-tube solid phase microextraction coupled with liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 2009, 49:108-114.
29. Dobrinas M., Choong E., Noetzli M., Cornuz J., Ansermot N., Eap C.B. Quantification of nicotine, cotinine, trans-3'-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass spectrometry procedure for a clinical study on smoking cessation. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2011, 879:3574-3582.
30. Onoue S., Yamamoto N., Seto Y., Yamada S. Pharmacokinetic study of nicotine and its metabolite cotinine to clarify possible association between smoking and voiding dysfunction in rats using UPLC-ESI-MS. Drug Metab. Pharmacokinet. 2011, 26:416-422.
31. Yamamoto N., Yoshida A., Taki Y., Onoue S., Kagawa Y., Yamada S. Up-regulation of nicotinic and muscarinic receptor mRNA in rat bladder by repeated administration of nicotine in relation to the pharmacokinetics. Life Sci. 2011, 89:343-348.
32. Kuhn J., Vollmer T., Martin C., Hendig D., Knabbe C. Fast and sample cleanup-free measurement of nicotine and cotinine by stable isotope dilution ultra-performance liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2012, 67/68:137-143.
33. Marclay F., Grata E., Perrenoud L., Saugy M. A one-year monitoring of nicotine use in sport: frontier between potential performance enhancement and addiction issues. Forensic. Sci. Int. 2011, 213:73-84.
34. ISO 5725-1, Accuracy (trueness and precision) of measurements methods and results-general principles and definitions, 1994.
35. ISO 5725-2, Accuracy (trueness and precision) of measurement methods and results-basic method for the determination of repeatability and reproducibility of a standard measurement method, 1994.
36. Cognard E., Staub C. Determination of nicotine and its major metabolite cotinine in plasma or serum by gas chromatography using ion-trap detection. Clin. Chem. Lab. Med. 2003, 41:1599-1607.
37. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
38. Matuszewski B.K. Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. J. Chromatogr. B 2006, 830:293-300.
39. van Loco J., Elskens M., Croux C., Beernaert H. Linearity of calibration curves: use and misuse of the correlation coefficient. Accred. Qual. Assur. 2002, 7:281-285.
40. Food and Drug Administration, Guidance for Industry on Bioanalytical Method Validation, May 2001.
41. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., Yacobi A. Pharm. Res. 2000, 17:1551-1557.